Allogeneic Peripheral Blood Stem Cell Transplantation is a Promising and Safe Choice for the Treatment of Refractory/Relapsed Acute Myelogenous Leukemia, Even with a Higher Leukemia BurdenWeiping Zhang, Jianmin Wang, Xiong Ni et al.|Biology of Blood and Marrow Transplantation|2013Cited by 39
Human mesenchymal stem cells derived exosomes inhibit the growth of acute myeloid leukemia cells via regulating miR-23b-5p/TRIM14 pathwayHui Cheng, Jie Ding, Gusheng Tang et al.|Molecular Medicine|2021Cited by 39